CLINICAL_TRIALS
research
· 2026-03-03
Clinical Trial Update: Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus [Phase 3]
Summary
Ongoing Phase 3 study evaluating the long-term safety and tolerability of Cenerimod in adults with systemic lupus erythematosus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Viatris Innovation GmbH | Conditions: Lupus Erythematosus, Systemic | Phase 3 | Status: ENROLLING_BY_INVITATION